相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Comparative Risk of Cardiovascular Events With Biologic and Synthetic Disease-Modifying Antirheumatic Drugs in Patients With Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
Siddharth Singh et al.
ARTHRITIS CARE & RESEARCH (2020)
Tofacitinib Treatment Is Associated With Modest and Reversible Increases in Serum Lipids in Patients With Ulcerative Colitis
Bruce E. Sands et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
Imbalance of the renin-angiotensin system may contribute to inflammation and fibrosis in IBD: a novel therapeutic target?
Mayur Garg et al.
GUT (2020)
Risk of acute arterial events associated with treatment of inflammatory bowel diseases: nationwide French cohort study
Julien Kirchgesner et al.
GUT (2020)
Ustekinumab Pharmacokinetics and Exposure Response in a Phase 3 Randomized Trial of Patients With Ulcerative Colitis
Omoniyi J. Adedokun et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
Safety of Janus Kinase Inhibitors in Patients with Inflammatory Bowel Diseases or Other Immune-mediated Diseases: a Systematic Review and Meta-Analysis
Pablo Olivera et al.
GASTROENTEROLOGY (2020)
Cardiovascular Risk in Individuals with Inflammatory Bowel Disease
Robertha Baccaro Biondi et al.
CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY (2020)
Retrospective Analysis of Safety of Vedolizumab in Patients With Inflammatory Bowel Diseases
Joseph Meserve et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Heart Disease and Stroke Statistics-2019 Update A Report From the American Heart Association
Emelia J. Benjamin et al.
CIRCULATION (2019)
Impact of Angiotensin II Signaling Blockade on Clinical Outcomes in Patients with Inflammatory Bowel Disease
Jeffrey D. Jacobs et al.
DIGESTIVE DISEASES AND SCIENCES (2019)
Aortic Stiffness in Patients With Inflammatory Bowel Disease Reduced After Anti-Tumor Necrosis Factor Therapy
Luca Zanoli et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Inflammation and Aortic Pulse Wave Velocity: A Multicenter Longitudinal Study in Patients With Inflammatory Bowel Disease
Luca Zanoli et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2019)
Association of Ustekinumab vs TNF Inhibitor Therapy With Risk of Atrial Fibrillation and Cardiovascular Events in Patients With Psoriasis or Psoriatic Arthritis
Moa P. Lee et al.
JAMA DERMATOLOGY (2019)
2019 update of the EULAR recommendations for the management of systemic lupus erythematosus
Antonis Fanouriakis et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Lipidomics in Ulcerative Colitis Reveal Alteration in Mucosal Lipid Composition Associated With the Disease State
Joseph Diab et al.
INFLAMMATORY BOWEL DISEASES (2019)
Inflammatory, Serological and Vascular Determinants of Cardiovascular Disease in Systemic Lupus Erythematosus Patients
Valentina Mercurio et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction
Jean-Claude Tardif et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Safety of Tofacitinib for Treatment of Ulcerative Colitis, Based on 4.4 Years of Data From Global Clinical Trials
William J. Sandborn et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Cardiovascular Risk Profile Among Patients With Inflammatory Bowel Disease: A Population-based Study of More Than 100 000 Individuals
Julie Aarestrup et al.
JOURNAL OF CROHNS & COLITIS (2019)
Measurement of Microvascular Function in Pediatric Inflammatory Bowel Disease
Rebecca Winderman et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2019)
Low-Dose Methotrexate for the Prevention of Atherosclerotic Events
Paul M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Cardiovascular Manifestations of Inflammatory Bowel Disease: Pathogenesis, Diagnosis, and Preventive Strategies
Diana-Maria Bunu et al.
GASTROENTEROLOGY RESEARCH AND PRACTICE (2019)
Assessment of the real-world safety profile of vedolizumab using the United States Food and Drug Administration adverse event reporting system
Raymond K. Cross et al.
PLOS ONE (2019)
Increased risk of acute arterial events in young patients and severely active IBD: a nationwide French cohort study
Julien Kirchgesner et al.
GUT (2018)
Long-term efficacy and safety of ustekinumab for Crohn's disease through the second year of therapy
W. J. Sandborn et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Increased Mortality Rates With Prolonged Corticosteroid Therapy When Compared With Antitumor Necrosis Factor-α-Directed Therapy for Inflammatory Bowel Disease
James D. Lewis et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2018)
Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium
Neeraj Narula et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2018)
Increased Risk of Acute Myocardial Infarction and Heart Failure in Patients With Inflammatory Bowel Diseases
Satimai Aniwan et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2018)
Cardiovascular disease in systemic lupus erythematosus: an update
Yudong Liu et al.
CURRENT OPINION IN RHEUMATOLOGY (2018)
Modulation of the interleukin-6 signalling pathway and incidence rates of atherosclerotic events and all-cause mortality: analyses from the Canakinumab Anti-Inflammatory Thrombosis Outcomes Study (CANTOS)
Paul M. Ridker et al.
EUROPEAN HEART JOURNAL (2018)
β-Blocker use is associated with a higher relapse risk of inflammatory bowel disease: a Dutch retrospective case-control study
Rose A. Willemze et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2018)
Age at disease onset of inflammatory bowel disease is associated with later extraintestinal manifestations and complications
Denise Herzog et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2018)
Infections and Cardiovascular Complications are Common Causes for Hospitalization in Older Patients with Inflammatory Bowel Diseases
Nghia H. Nguyen et al.
INFLAMMATORY BOWEL DISEASES (2018)
Heart Under Attack: Cardiac Manifestations of Inflammatory Bowel Disease
Natalie E. Mitchell et al.
INFLAMMATORY BOWEL DISEASES (2018)
Vascular Endothelial Dysfunction in Inflammatory Bowel Diseases: Pharmacological and Nonpharmacological Targets
Antonietta Gerarda Gravina et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2018)
Impact of Changes in Inflammation on Estimated Ten-Year Cardiovascular Risk in Rheumatoid Arthritis
Zhi Yu et al.
ARTHRITIS & RHEUMATOLOGY (2018)
Clinical activity is an independent risk factor of ischemic heart and cerebrovascular arterial disease in patients with inflammatory bowel disease
Guillaume Le Gall et al.
PLOS ONE (2018)
Short and long-term effectiveness and safety of vedolizumab in inflammatory bowel disease: results from the ENEIDA registry
Maria Chaparro et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Subclinical Atherosclerosis in Patients With Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis
Guo-Cui Wu et al.
ANGIOLOGY (2017)
EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update
R. Agca et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Inflammatory processes in cardiovascular disease: a route to targeted therapies
Neil Ruparelia et al.
NATURE REVIEWS CARDIOLOGY (2017)
BIOLOGIC THERAPY AND IMMUNODULATORS ARE ASSOCIATED WITH DECREASED RISK OF CARDIOVASCULAR EVENTS IN PATIENTS WITH IMMUNE-MEDIATED INFLAMMATORY DISEASES: A SYSTEMATIC REVIEW AND META-ANALYSIS
Mathurin Fumery et al.
GASTROENTEROLOGY (2017)
Longterm Hydroxychloroquine Therapy and Low-dose Aspirin May Have an Additive Effectiveness in the Primary Prevention of Cardiovascular Events in Patients with Systemic Lupus Erythematosus
Serena Fasano et al.
JOURNAL OF RHEUMATOLOGY (2017)
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
P. M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Long-term safety of tofacitinib for the treatment of rheumatoid arthritis up to 8.5 years: integrated analysis of data from the global clinical trials
Stanley B. Cohen et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Subclinical atherosclerosis in Systemic Lupus Erythematosus: Comparable risk with Diabetes Mellitus and Rheumatoid Arthritis
Maria G. Tektonidou et al.
AUTOIMMUNITY REVIEWS (2017)
Comparison of lipid and lipid-associated cardiovascular risk marker changes after treatment with tocilizumab or adalimumab in patients with rheumatoid arthritis
Cem Gabay et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Endothelial function and cardiovascular risk in patients with inflammatory bowel disease in remission phase
Mariabeatrice Principi et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2016)
Response to biological treatment and subsequent risk of coronary events in rheumatoid arthritis
Lotta Ljung et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Cardiovascular disease in patients with inflammatory bowel disease: An issue in no guidelines land
Marco Zuin et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2016)
Arterial stiffness, atherosclerosis and cardiovascular risk: Pathophysiologic mechanisms and emerging clinical indications
Carlo Palombo et al.
VASCULAR PHARMACOLOGY (2016)
The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis
Camille Roubille et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Inflammatory bowel disease, liver diseases and endothelial function: is there a linkage?
Marco Matteo Ciccone et al.
JOURNAL OF CARDIOVASCULAR MEDICINE (2015)
Inflammatory bowel disease pathogenesis: Where are we?
Claudio Fiocchi
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2015)
Subclinical atherosclerosis in patients with rheumatoid arthritis A meta-analysis of literature studies
Pasquale Ambrosino et al.
THROMBOSIS AND HAEMOSTASIS (2015)
Arterial structure and function in inflammatory bowel disease
Luca Zanoli et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
The Ability of the 2013 American College of Cardiology/American Heart Association Cardiovascular Risk Score to Identify Rheumatoid Arthritis Patients With High Coronary Artery Calcification Scores
Vivian K. Kawai et al.
ARTHRITIS & RHEUMATOLOGY (2015)
The effect of interleukin-1 receptor antagonist therapy on markers of inflammation in non-ST elevation acute coronary syndromes: the MRC-ILA Heart Study
Allison C. Morton et al.
EUROPEAN HEART JOURNAL (2015)
Risk of Ischaemic Heart Disease in Patients with Inflammatory Bowel Disease: Cohort Study Using the General Practice Research Database
Helen Close et al.
PLOS ONE (2015)
Predictors of cardiovascular events in patients with systemic lupus erythematosus (SLE): a systematic review and meta-analysis
Flavia Ballocca et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2015)
Definitions of and contributions to cardiovascular disease in systemic lupus erythematosus
Johanna T. Gustafsson et al.
AUTOIMMUNITY (2014)
Prognosis After First-Time Myocardial Infarction in Patients With Inflammatory Bowel Disease According to Disease Activity Nationwide Cohort Study
Soren Lund Kristensen et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2014)
Risk of Cerebrovascular Accidents and Ischemic Heart Disease in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis
Siddharth Singh et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2014)
Long-term Risk of Acute Coronary Syndrome in Patients with Inflammatory Bowel Disease: A 13-year Nationwide Cohort Study in an Asian Population
Ming-Shian Tsai et al.
INFLAMMATORY BOWEL DISEASES (2014)
From the Medical Board of the National Psoriasis Foundation: The risk of cardiovascular disease in individuals with psoriasis and the potential impact of current therapies
Jeremy Hugh et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2014)
2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk
Bruce Andrus et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Mortality and years of potential life loss in systemic lupus erythematosus: a population-based cohort study
K. Lerang et al.
LUPUS (2014)
Telmisartan Attenuates Colon Inflammation, Oxidative Perturbations and Apoptosis in a Rat Model of Experimental Inflammatory Bowel Disease
Hany H. Arab et al.
PLOS ONE (2014)
Glucocorticoid Dose Thresholds Associated With All-Cause and Cardiovascular Mortality in Rheumatoid Arthritis
Inmaculada del Rincon et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Heart failure risk among patients with rheumatoid arthritis starting a TNF antagonist
Daniel H. Solomon et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Long-term safety of ustekinumab in patients with moderate-to-severe psoriasis: final results from 5 years of follow-up
K. A. Papp et al.
BRITISH JOURNAL OF DERMATOLOGY (2013)
The Fatty Acid Profile of the Erythrocyte Membrane in Initial-Onset Inflammatory Bowel Disease Patients
Kan Uchiyama et al.
DIGESTIVE DISEASES AND SCIENCES (2013)
Dyslipidemia and Inflammation in Patients with Inflammatory Bowel Disease
Fatih Karaahmet et al.
DIGESTIVE DISEASES AND SCIENCES (2013)
2013 ESH/ESC Guidelines for the management of arterial hypertension
Giuseppe Mancia et al.
EUROPEAN HEART JOURNAL (2013)
Risk of ischaemic heart disease in patients with inflammatory bowel disease: a nationwide Danish cohort study
Christine Rungoe et al.
GUT (2013)
Endothelial function and cardiovascular risk in active inflammatory bowel diseases
Mariabeatrice Principi et al.
Journal of Crohns & Colitis (2013)
Disease Activity in Inflammatory Bowel Disease Is Associated with Increased Risk of Myocardial Infarction, Stroke and Cardiovascular Death - A Danish Nationwide Cohort Study
Soren Lund Kristensen et al.
PLOS ONE (2013)
Usefulness of Risk Scores to Estimate the Risk of Cardiovascular Disease in Patients With Rheumatoid Arthritis
Cynthia S. Crowson et al.
AMERICAN JOURNAL OF CARDIOLOGY (2012)
Aspirin, Nonsteroidal Anti-inflammatory Drug Use, and Risk for Crohn Disease and Ulcerative Colitis A Cohort Study
Ashwin N. Ananthakrishnan et al.
ANNALS OF INTERNAL MEDICINE (2012)
The Assessment of Endothelial Function From Research Into Clinical Practice
Andreas J. Flammer et al.
CIRCULATION (2012)
Statins are associated with reduced use of steroids in inflammatory bowel disease: A retrospective cohort study
Seth D. Crockett et al.
INFLAMMATORY BOWEL DISEASES (2012)
Inflammatory Bowel Disease Is Associated With an Increased Incidence of Cardiovascular Events
Andres J. Yarur et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
The risk of myocardial infarction in rheumatoid arthritis and diabetes mellitus: a Danish nationwide cohort study
Jesper Lindhardsen et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: a population-based nationwide study
Michael D. Kappelman et al.
GUT (2011)
Association between NOD2/CARD15 polymorphisms and coronary artery disease: a case-control study
Sara Galluzzo et al.
HUMAN IMMUNOLOGY (2011)
Release of sphingosine-1-phosphate from human platelets is dependent on thromboxane formation
T. Ulrych et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)
Importance of cumulative exposure to elevated cholesterol and blood pressure in development of atherosclerotic coronary artery disease in systemic lupus erythematosus: a prospective proof-of-concept cohort study
Mandana Nikpour et al.
ARTHRITIS RESEARCH & THERAPY (2011)
Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis
Sven Trelle et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Novel Lipid Mediators Promote Resolution of Acute Inflammation Impact of Aspirin and Statins
Matthew Spite et al.
CIRCULATION RESEARCH (2010)
Risk of Arterial Thrombotic Events in Inflammatory Bowel Disease
Christina Ha et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRE Investigation
V. P. van Halm et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Adverse events of low- to medium-dose oral glucocorticoids in inflammatory diseases: a meta-analysis
J. N. Hoes et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Evidence of Endothelial Dysfunction in Patients With Inflammatory Bowel Disease
Idan Roifman et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2009)
Effects of Methotrexate on Plasma Cytokines and Cardiac Remodeling and Function in Postmyocarditis Rats
Zhengang Zhang et al.
MEDIATORS OF INFLAMMATION (2009)
Risk of Cardiovascular Mortality in Patients With Rheumatoid Arthritis: A Meta-Analysis of Observational Studies
J. Antonio Avina-Zubieta et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2008)
The incidence of arterial thromboembolic diseases in inflammatory bowel disease: A population-based study
Charles N. Bernstein et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Paul M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Enhanced atherogenesis and altered high density lipoprotein in patients with Crohn's disease
Sander I. van Leuven et al.
JOURNAL OF LIPID RESEARCH (2007)
Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor α therapy -: Results from the British Society for Rheumatology Biologics Register
W. G. Dixon et al.
ARTHRITIS AND RHEUMATISM (2007)
Glucocorticoids and cardiovascular events in rheumatoid arthritis - A population-based cohort study
John M. Davis et al.
ARTHRITIS AND RHEUMATISM (2007)
Preclinical carotid atherosclerosis in patients with rheumatoid arthritis
MJ Roman et al.
ANNALS OF INTERNAL MEDICINE (2006)
COX isoforms in the cardiovascular system: understanding the activities of non-steroidal anti-inflammatory drugs
JA Mitchell et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Blockade of interleukin-12 function by protein vaccination attenuates atherosclerosis
AD Hauer et al.
CIRCULATION (2005)
Intestinal antiinflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator-activated receptor-γ
C Rousseaux et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Clinical pharmacology of platelet, monocyte, and vascular cyclooxygenase inhibition by naproxen and low-dose aspirin in healthy subjects
ML Capone et al.
CIRCULATION (2004)
Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease
L Wei et al.
ANNALS OF INTERNAL MEDICINE (2004)
Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-α, in patients with moderate-to-severe heart failure -: Results of the Anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial
ES Chung et al.
CIRCULATION (2003)
Mechanisms involved in the side effects of glucocorticoids
H Schäcke et al.
PHARMACOLOGY & THERAPEUTICS (2002)
Anti-tumor necrosis factor-α antibody limits heart failure in a transgenic model
T Kadokami et al.
CIRCULATION (2001)
分享论文
